Oral Solid Dosage Contract Manufacturing Market Size

Oral Solid Dosage Contract Manufacturing Market Size

Oral Solid Dosage Contract Manufacturing Market size was valued at USD 35.6 billion in 2023 and is anticipated to grow at a CAGR of 5.6% between 2024 and 2032, driven by rising trend of outsourcing manufacturing by pharmaceutical companies. Outsourcing allows pharmaceutical companies to leverage the expertise and infrastructure of contract manufacturing organizations (CMOs) without the need for significant capital investment in manufacturing facilities and equipment.

To get key market trends

  Download Free Sample

Furthermore, advancements in pharmaceutical technology and formulation techniques are increasing the efficiency and quality of oral solid dosage manufacturing, driving more companies to opt for contract manufacturing services. Additionally, the increasing demand for pharmaceutical products, driven by the growing global population and the prevalence of chronic diseases, further fuels the market growth.
 

Oral solid dosage contract manufacturing refers to the outsourcing of the production of tablets, capsules, or other solid forms of medication to a third-party manufacturer. This type of contract manufacturing is common in the pharmaceutical industry, where companies may not have the capacity or expertise to manufacture certain medications in-house. Contract manufacturing allows pharmaceutical companies to focus on their core competencies, such as research and development, while leveraging the manufacturing capabilities of specialized contract manufacturers.